Back
HealthEquity 10K Form
Buy
55
HQY
HealthEquity
Last Price:
104.21
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-03 | 10Q | HQY/HealthEquity Quarterly |
2023-12-05 | 10Q | HQY/HealthEquity Quarterly |
2023-09-05 | 10Q | HQY/HealthEquity Quarterly |
2023-06-07 | 10Q | HQY/HealthEquity Quarterly |
2022-12-08 | 10Q | HQY/HealthEquity Quarterly |
2022-09-08 | 10Q | HQY/HealthEquity Quarterly |
Receive HQY News And Ratings
See the #1 stock for the next 7 days that we like better than HQY
HQY Financial Statistics
Sales & Book Value
Annual Sales: | $999.59M |
---|---|
Cash Flow: | $-100.95M |
Price / Cash Flow: | 0 |
Annual Sales: | $24.70 |
Price / Book: | 4.22 |
Profitability
EPS (TTM): | 1.20000 |
---|---|
Net Income (TTM): | $105.67M |
Gross Margin: | $622.64M |
Return on Equity: | 5.17% |
Return on Assets: | 3.29% |
HealthEquity Earnings Forecast
Key HealthEquity Financial Ratios
- The Gross Profit Margin over the past 12 years for HQY is 62.29%.
- The Selling, General & Administrative Expenses for HQY have been equal to 18.30% of Gross Profit Margin.
- The Research & Development expenses have been 21.89% of Revenue.
- The Interest Expense is 99.54% of Operating Income.
- The Net Earning history of HQY is 5.57% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 7 years.
HealthEquity Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | HQY |
CUSIP: | 42226A |
Website: | healthequity.com |
Debt
Debt-to-Equity Ratio: | 0.51 |
---|---|
Current Ratio: | 4.1 |
Quick Ratio: | 3.6 |
Price-to-Earnings
Trailing P/E Ratio: | 162.89 |
---|---|
Forward P/E Ratio: | 28.04 |
HQY Technical Analysis vs Fundamental Analysis
Buy
55
HealthEquity (HQY)
is a Buy
Is HealthEquity a Buy or a Sell?
-
HealthEquity stock is rated a Buy
The current HealthEquity [HQY] share price is $104.25. The Score for HQY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.